GE HealthCare announced that the NCCN Guidelines for Clinical Oncology now recommend FES PET for systemic staging in patients ...

Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However ...

Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

The pivotal AMPLIFY trial aims to support FDA approval of ⁶⁴Cu-SAR-bisPSMA as a best-in-class imaging tool in prostate cancer ...

Intermountain Health Park City Hospital CEO Lori Weston shares details on the $40 million investment to add a 10,000 square ...

Breast cancer remains a leading cause of cancer-related mortality globally, underscoring the critical need for early ...

Dr Kunjahari Medhi, is a Medical & Haemato oncologist, Medanta hospital, Gurgaon, 5 star rated in his Google Profile Review. He comes to me as an amiable, family doctor who puts patients at ease ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...

30 patients of endometrial cancer were investigated and the FDG-PET imaging results were compared with CT and/or MRI and the results of postoperative histopathological results. [76] With regard to ...

During a live event, Deborah Wong, MD, PhD, discussed the role of EBV and challenges in nasopharyngeal cancer diagnosis with ...

Television actress Dipika Kakar has not been keeping well for the past few days. Recently, her husband and actor Shoaib ...

The results were similar across all income levels. Pet advocates say that shows a need for vets to adjust to address clients' ...